City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
March 7, 2017 | Samantha Bonar
Doctors nationwide are mourning the loss of Thomas E. Starzl, the surgeon and researcher who pioneered the liver transplant and the medications that made the procedure successful in the long term. Starzl died on March 4 at his home in Pittsburg at age 90.
December 5, 2015 | Letisia Marquez
The United States spends $2.6 trillion each year on healthcare – that’s more than the gross domestic product of Russia, Brazil, Italy and Canada, says Joseph Alvarnas, M.D., director of value-based analytics at City of Hope. There may be a better way.
May 29, 2015 | Nancy Brands Ward
Ranked by U.S. News & World Report as one of the elite places in the world to receive cancer care, City of Hope brings a mission-driven commitment to treating patients and their families through what may be the most intense experience of their lives.
February 3, 2015 | Nicole White
"Not beyond us." On World Cancer Day , researchers and caregivers around the globe are embracing this refrain. On World Cancer Day, healthy lifestyles, early detection of cancers, better quality of life and access to cancer care for all are not beyond us.
January 1, 2015 | Nicole White
HIV/AIDS researchers are determined not only to cure the disease, but to develop ever-more-effective treatments until that ultimate goal is reached. In 2015, they will gain ground in both endeavors. City of Hope researchers are developing potential cures for HIV/AIDS while improving treatments for those currently living with the disease.
December 8, 2014 | Nicole White
When it comes to research into the treatment of hematologic cancers, City of Hope scientists stand out. One study that they presented this week at the annual meeting of the American Society of Hematology suggests a new standard of care for HIV-associated lymphoma, another offers promise for the treatment of relapsing or treatment-resistant lymphoma, and still another points to more effective treatment for acute lymphoblastic leukemia.
December 8, 2014 | Nicole White
Patients with HIV-associated lymphoma may soon have increased access to the current standard of care for some non-HIV infected patients – autologous stem cell transplants. City of Hope's Joseph Alvarnas shares results from a City of Hope study at the annual ASH meeting that supports change to standard of care for HIV lymphoma.
November 21, 2014 | Valerie Zapanta
When it comes to cancer, your family history may provide more questions than answers: How do my genes increase my risk for cancer? No one in my family has had cancer; does that mean I won’t get cancer? What cancers are common in certain populations and ethnicities? City of Hope experts have some guidance.
October 27, 2014 | Valerie Zapanta
Genetics, genes, genome, genetic risk ... Such terms are becoming increasingly familiar to even nonresearchers as studies and information about the human make-up become more extensive and more critical.